CG
NXTM

Cutler Group’s NxStage Medical Inc. NXTM Stock Holding History

Cutler Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,200
Closed -$8K – 7188
2017
Q2 		$8K Buy
20,200
+19,200
+1,920% +$475K ﹤0.01% 4467
2017
Q1 		$3K Buy
+1,000
New +$27.6K ﹤0.01% 5305
2016
Q2 		– Sell
-2,900
Closed -$3K – 7661
2016
Q1 		$3K Buy
+2,900
New +$48.6K ﹤0.01% 5407

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's NXTM Position: Q3 2017 in Review

Cutler Group sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 44,266 shares — an estimated $1.18M sold.

Cutler Group first reported a position in NXTM in Q4 2015 and held it in 7 quarters. The position peaked at $1.11M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Cutler Group reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 44,266 NxStage Medical Inc. shares in Q3 2017, an estimated $1.18M.
  • Cutler Group first reported a position in NxStage Medical Inc. in Q4 2015 and held it in 7 quarters.
  • Cutler Group's NxStage Medical Inc. position peaked at $1.11M in Q2 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.